Chicago dominates the Illinois ketamine therapy market, with a mix of academic medical center programs, private psychiatry practices, and standalone infusion clinics serving patients throughout the metro area. Illinois has been recognized as having one of the strongest mental health parity laws in the nation — the Kennedy Forum has described Illinois as a national leader, citing SB 1707's annual compliance audit requirement and HB 4475, effective January 1, 2026, which mandates in-network mental health reimbursement at 141% or more of Medicare rates. HCSC, the parent company of Blue Cross Blue Shield of Illinois, explicitly covers Spravato under medical policy RX501.105. IV ketamine infusions in Illinois typically range from $350–$500 per session.

Modalities Available

Illinois clinics offer IV ketamine infusion, intramuscular (IM) injection, Spravato (esketamine) at certified REMS centers, and oral/sublingual ketamine, including telehealth-based at-home programs. IV infusion is the most common modality in the Chicago metro. BCBS Illinois (through HCSC) explicitly covers Spravato under medical policy RX501.105. Spravato received FDA approval as a standalone monotherapy for treatment-resistant depression in January 2025, expanding its clinical use. The DEA's telehealth prescribing extension through December 31, 2026 allows patients to access at-home sublingual ketamine through telehealth providers without an in-person visit.

Cost & Pricing

IV ketamine infusions in Illinois typically range from $350–$500 per session, with most clinics pricing in the $300–$475 range. Pricing is driven by business model and service bundling rather than clinic geography. Most providers offer package pricing for the standard 6-infusion induction protocol. Spravato is covered by BCBS Illinois and most major commercial plans with prior authorization.

Insurance Coverage

Illinois has been described as having 'the strongest mental health parity law in the nation' by the Kennedy Forum. SB 1707 requires annual insurance compliance audits. HB 4475, effective January 1, 2026, mandates that in-network mental health providers be reimbursed at 141% or more of Medicare rates — one of the most aggressive reimbursement equity requirements in the country. HB 5395 eliminates prior authorization requirements for the first 72 hours of inpatient mental health stays. HCSC (parent of Blue Cross Blue Shield of Illinois) explicitly covers Spravato under medical policy RX501.105. IV ketamine infusions are generally paid out-of-pocket. Many clinics accept HSA and FSA payments.

Psilocybin Legislation

Two psilocybin regulation bills — SB 2184 and HB 2992 — were introduced in Illinois but neither advanced during the most recent legislative session. Psilocybin therapy is not currently available in Illinois.

Conditions Treated

Illinois ketamine clinics treat treatment-resistant depression, anxiety disorders, PTSD, OCD, bipolar depression, suicidal ideation, and chronic pain. Chicago's clinical landscape includes academic medical center programs with strong physician oversight alongside specialized integrative mental health practices.

Frequently Asked Questions

Find Ketamine Clinics in Illinois

Browse 16 ketamine therapy providers in Illinois →